Hero image with Pittsburgh background pittplusme.org/study/1706

This study is not currently recruiting. Please check back at a later time.


Have you been diagnosed with metastatic castration-resistant prostate cancer? If so, you may be eligible for a research study to help find out what effects, good and bad, that an investigational drug called tazemetostat has on you and your prostate cancer. Reimbursement for study visits is provided.

PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet